Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Paula L Kirby"'
Autor:
Amanda J Cross, Emma C Robbins, Kevin Pack, Iain Stenson, Paula L Kirby, Bhavita Patel, Matthew D Rutter, Andrew M Veitch, Brian P Saunders, Matthew Little, Alastair Gray, Stephen W Duffy, Kate Wooldrage
Publikováno v:
Health Technology Assessment, Vol 26, Iss 26 (2022)
Background: Colonoscopy surveillance is recommended for some patients post polypectomy. The 2002 UK surveillance guidelines classify post-polypectomy patients into low, intermediate and high risk, and recommend different strategies for each classific
Externí odkaz:
https://doaj.org/article/94dff7c1d3384ac4bb56d401693de569
Autor:
Zul Premji, Rich E Umeh, Seth Owusu-Agyei, Fabian Esamai, Emmanuel U Ezedinachi, Stephen Oguche, Steffen Borrmann, Akintunde Sowunmi, Stephan Duparc, Paula L Kirby, Allan Pamba, Lynda Kellam, Robert Guiguemdé, Brian Greenwood, Stephen A Ward, Peter A Winstanley
Publikováno v:
PLoS ONE, Vol 4, Iss 8, p e6682 (2009)
BACKGROUND:Chlorproguanil-dapsone-artesunate (CDA) was developed as an affordable, simple, fixed-dose artemisinin-based combination therapy for use in Africa. This trial was a randomized parallel-group, double-blind, double-dummy study to compare CDA
Externí odkaz:
https://doaj.org/article/bd31c1633a2c46e6a96595b2156737bd
Autor:
Daniel G Wootton, Hyginus Opara, Giancarlo A Biagini, Maxwell K Kanjala, Stephan Duparc, Paula L Kirby, Mary Woessner, Colin Neate, Maggie Nyirenda, Hannah Blencowe, Queen Dube-Mbeye, Thomas Kanyok, Stephen Ward, Malcolm Molyneux, Sam Dunyo, Peter A Winstanley
Publikováno v:
PLoS ONE, Vol 3, Iss 3, p e1779 (2008)
The objective of this study was to determine the appropriate dose of artesunate for use in a fixed dose combination therapy with chlorproguanil-dapsone (CPG-DDS) for the treatment of uncomplicated falciparum malaria.Open-label clinical trial comparin
Externí odkaz:
https://doaj.org/article/17da3911aa0143e58c17fdf549eaf367
Autor:
Paula L Kirby, Emma C Robbins, Brian P. Saunders, Bhavita Patel, Iain Stenson, Amanda J. Cross, Kevin Pack, Matthew D. Rutter, Andrew Veitch, Stephen W. Duffy, Kate Wooldrage
Publikováno v:
Gut
ObjectivePostpolypectomy colonoscopy surveillance aims to prevent colorectal cancer (CRC). The 2002 UK surveillance guidelines define low-risk, intermediate-risk and high-risk groups, recommending different strategies for each. Evidence supporting th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::298c929326914736a3d21fbad929fa7b
https://pubmed.ncbi.nlm.nih.gov/31953252
https://pubmed.ncbi.nlm.nih.gov/31953252
Autor:
Peter Winstanley, Stephan Duparc, Ann K. Miller, Daniel G. Wootton, Paula L. Kirby, Nibedita Bandyopadhyay, Stephen A. Ward
Publikováno v:
European Journal of Clinical Pharmacology. 65:977-987
Chlorproguanil (CPG)-dapsone (DDS)-artesunate was in development for the treatment of uncomplicated Plasmodium falciparum malaria. The pharmacokinetics of CPG, DDS, artesunate and their metabolites chlorcycloguanil (CCG), monoacetyl dapsone (MADDS) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9b1e0a0f555ec68ed3ced8e54d6a1ef
https://doi.org/10.1007/s00228-009-0672-1
https://doi.org/10.1007/s00228-009-0672-1
Autor:
Steffen Borrmann, Stephen Oguche, Fabian Esamai, Akintunde Sowunmi, Stephan Duparc, Lynda Kellam, Stephen A. Ward, Paula L. Kirby, Peter Winstanley, Brian Greenwood, Allan Pamba, R. E. Umeh, Seth Owusu-Agyei, Zul Premji, Robert T. Guiguemdé, Emmanuel U. Ezedinachi
Publikováno v:
PLoS ONE, Vol 4, Iss 8, p e6682 (2009)
PLoS ONE
PLoS ONE
BACKGROUND Chlorproguanil-dapsone-artesunate (CDA) was developed as an affordable, simple, fixed-dose artemisinin-based combination therapy for use in Africa. This trial was a randomized parallel-group, double-blind, double-dummy study to compare CDA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49916fdb06a2bdd4831086c5e1e7ca79
http://digitallibrary.ihi.or.tz/208/
http://digitallibrary.ihi.or.tz/208/
Autor:
Sam Dunyo, Malcolm E. Molyneux, Maggie Nyirenda, Stephan Duparc, Peter Winstanley, Paula L. Kirby, Maxwell Kanjala, Hyginus Opara, Thomas Kanyok, Daniel G. Wootton, Mary Woessner, Giancarlo A. Biagini, Hannah Blencowe, Colin Neate, Queen Dube-Mbeye, Stephen A. Ward
Publikováno v:
PLoS ONE, Vol 3, Iss 3, p e1779 (2008)
PLoS ONE
PLoS ONE
UNLABELLED: The objective of this study was to determine the appropriate dose of artesunate for use in a fixed dose combination therapy with chlorproguanil-dapsone (CPG-DDS) for the treatment of uncomplicated falciparum malaria. METHODS: Open-label c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a67d7e389ae7bd9d7bbe4f9dd0d8b482
https://doi.org/10.1371/journal.pone.0001779
https://doi.org/10.1371/journal.pone.0001779